Diagnosis Test of Real-time Polymerase Chain Reaction (RT-PCR) for Pulmonary Tuberculosis
NCT ID: NCT06284187
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2023-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
OBJECTIVE: To evaluate the diagnosis value of the real-time multiplex PCR by using Allplex™ MTB/MDRe Detection kit to detect MTB from sputum specimens with a gold standard TB culture.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
NCT07170735
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
NCT03042754
Multiplex PCR -Microarray-based Assay in the Detection of Mycobacterium
NCT03794284
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
NCT06439810
Establishing a Diagnostic Test for Non-tuberculous Mycobacteria Lung Infection Using Non-tuberculous Mycobacteria Antigen Stimulation Test: From Immune Base, Standardized Setup to Validation
NCT01676142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 15 years and older
Exclusion Criteria
* Non-tuberculous mycobacteria (NTM) detection
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khon Kaen Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kriengsak Vacharanukulkieti
Director of Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kriengsak Vacharanukulkieti, Medicine
Role: PRINCIPAL_INVESTIGATOR
Khon Kaen Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thananit Sangkomkamhang
Khon Kaen, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KhonKaenH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.